Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neha Mehta

Showing results (91-100 of 158) with videos related to

Pageof 16
Sort By:
Chemosphere|May 18, 2020
Incorporating oral bioaccessibility into human health risk assessment due to potentially toxic elements in extractive waste and contaminated soils from an abandoned mine siteNeha Mehta, Sabrina Cipullo, Tatiana Cocerva, et al.
Journal of Viral Hepatitis|February 10, 2026
Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCCMaría Fernanda Guerra-Veloz, Sital Shah, Beatrice Emmanouil, et al.
European Journal of Dermatology : EJD|February 2, 2022
Scarring alopecia developing after mogamulizumab-associated rashNeel S Raval, Caroline K Snowden, Karlee S De Monnin, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|September 22, 2024
Towards a unified carbon accounting landscapeLewis J McDonald, Jose Luis Hernandez Galvan, Chukwudi Emelue, et al.
Pilot and Feasibility Studies|April 1, 2026
A co-created randomised controlled feasibility trial of a peer-led complex oral health intervention in UK secondary schools: the RAISED In Yorkshire RiY study protocolYasmen Elsadek, Aruche-A-Noor Hamid, Poonam Anand, et al.
Plos One|November 22, 2008
Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in NigeriaVera Halpern, Folasade Ogunsola, Orikomaba Obunge, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 18, 2011
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populationsNeha Mehta, Alan S Wayne, Youn H Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 17, 2013
A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remissionNeha Mehta, Jocelyn C Maragulia, Allison Moskowitz, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2024
A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell LymphomasNicole Foley, Peter A Riedell, Nancy L Bartlett, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2023
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot StudiesDilan A Patel, Fei Wan, Kathryn Trinkaus, et al.
Pageof 16

Showing results (91-100 of 158) with videos related to

Sort By:
Pageof 16
Chemosphere|May 18, 2020
Incorporating oral bioaccessibility into human health risk assessment due to potentially toxic elements in extractive waste and contaminated soils from an abandoned mine siteNeha Mehta, Sabrina Cipullo, Tatiana Cocerva, et al.
Journal of Viral Hepatitis|February 10, 2026
Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCCMaría Fernanda Guerra-Veloz, Sital Shah, Beatrice Emmanouil, et al.
European Journal of Dermatology : EJD|February 2, 2022
Scarring alopecia developing after mogamulizumab-associated rashNeel S Raval, Caroline K Snowden, Karlee S De Monnin, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|September 22, 2024
Towards a unified carbon accounting landscapeLewis J McDonald, Jose Luis Hernandez Galvan, Chukwudi Emelue, et al.
Pilot and Feasibility Studies|April 1, 2026
A co-created randomised controlled feasibility trial of a peer-led complex oral health intervention in UK secondary schools: the RAISED In Yorkshire RiY study protocolYasmen Elsadek, Aruche-A-Noor Hamid, Poonam Anand, et al.
Plos One|November 22, 2008
Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in NigeriaVera Halpern, Folasade Ogunsola, Orikomaba Obunge, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 18, 2011
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populationsNeha Mehta, Alan S Wayne, Youn H Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 17, 2013
A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remissionNeha Mehta, Jocelyn C Maragulia, Allison Moskowitz, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2024
A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell LymphomasNicole Foley, Peter A Riedell, Nancy L Bartlett, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2023
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot StudiesDilan A Patel, Fei Wan, Kathryn Trinkaus, et al.
Pageof 16